Clinical Trials Directory

Trials / Unknown

UnknownNCT06028256

Norepinephrine Prevent Post-induction Hypotension in High-risk Patients

Continuous Norepinephrine Infusion Before General Anesthesia to Prevent Post-induction Hypotension in High-risk Patients Undergoing Major Noncardiac Surgery

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
First Affiliated Hospital of Kunming Medical University · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

The investigators aimed to investigate the effects of continuous infusion of norepinephrine before and after general anesthesia induction on the occurrence of post-induction hypotension.

Detailed description

Intraoperative hypotension is common after general anesthesia induction and is associated with adverse postoperative events. Norepinephrine is one of the most applied vasopressors in clinical to treat intraoperative hypotension. Due to the absence of effective measures for predicting intraoperative hypotension, infusing norepinephrine before and during anesthesia induction may reduce intraoperative hypotension. There is currently a lack of research regarding whether continuous norepinephrine infusion before and during the induction of general anesthesia can mitigate or prevent post-induction hypotension. The investigators aim to investigate the effects of continuous infusion of norepinephrine before and after general anesthesia induction on the occurrence of post-induction hypotension.

Conditions

Interventions

TypeNameDescription
DRUGNorepinephrine HydrochlorideBoth arms of patients will receive standard anesthesia and surgical management. Radial artery cannulation and invasive blood pressure monitoring will be perform. Norepinephrine will be pumped at a rate of 10 ml/h for 5 minutes before anesthesia induction to skin incision.
DRUGPlaceboNormal saline will be pumped at a rate of 10 ml/h for 5 minutes before anesthesia induction to skin incision.

Timeline

Start date
2023-10-01
Primary completion
2024-04-01
Completion
2024-10-01
First posted
2023-09-08
Last updated
2023-09-08

Source: ClinicalTrials.gov record NCT06028256. Inclusion in this directory is not an endorsement.